A Prescription-Event Monitoring (PEM) Study of Tiotropium

Boehringer Ingelheim

Status: Completed

Conditions: Pulmonary Disease, Chronic Obstructive

Treatments: Drug: Tiotropium

Study type: Observational

Funder types: Industry

Identifiers

NCT02196194

205.290

Details and patient eligibility

About

This prescription-event monitoring study was based upon 'event' monitoring and so capable of identifying signals of events that might be associated with the use of tiotropium, which none of the participating general practitioners (GPs) suspected to be an adverse drug reaction. The methodology of this study readily permits follow up of specific events and the obtaining of additional data as appropriate.

Enrollment: 13,891 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients who were prescribed tiotropium

Exclusion criteria

• not applicable

Trial design

13,891 participants in 1 patient group

tiotropium

Treatment:

Drug: Tiotropium